南方錳業(01091.HK)預計上半年利潤不少於1.5億港元
格隆匯8月5日丨南方錳業(01091.HK)公告,與截至2024年6月30日止六個月歸屬於公司所有者的虧損約162.8百萬港元相比,集團預計於2025年上半年錄得歸屬於公司所有者的利潤將爲不少於150.0百萬港元。
預期由虧轉盈的主要原因如下:1.管理層積極優化貿易產品結構,推動集團的貿易業務於2025年上半年實現扭虧爲盈;2.管理層在生產、採購、招標、運營等關鍵環節全面加強成本管控,取得顯著成效;及3.金融資產減值損失減少。於2024年上半年,集團確認了應收聯營公司獨山金孟錳業有限公司款項的減值。該減值乃由於集團清償向該聯營公司的銀行融資所授予的企業擔保相關的擔保責任而產生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.